Moving Forward with New Leadership

Steve Case, Accelerate Brain Cancer Cure’s Board of Directors Chairman

In January of 2006, we brought Kate Carr on board as President and CEO to continue the momentum established since our 2001 inception and bring new energy to our mission. Kate is leading the organization’s revitalized efforts to increase the number of potential therapies discovered and move them rapidly into the clinic for patients.

   
 

Message from Kate Carr

Accelerate Brain Cancer Cure President and CEO

My first eight months with Accelerate Brain Cancer Cure have been positively invigorating. I approach my role with Accelerate Brain Cancer Cure with great optimism and hope. Time and again, I hear from researchers and clinicians about their excitement surrounding the emerging possibilities for brain cancer patients. Our vision of making brain cancer a manageable disease is the motivation we use to fuel our energy and activities.

 
   
 

Accelerate Brain Cancer Cure Announces its 2006 Project Award Recipients

Since its inception, Accelerate Brain Cancer Cure has committed funding to advance translational research across a broad range of promising treatment strategies for brain cancer. After rigorous evaluation and deliberation by our team of reviewers, Accelerate Brain Cancer Cure is pleased to have selected eight recipients whose work holds near-term potential to improve the lives of those with brain cancer and will drive us closer to finding a cure.

 
   
 

Spotlight on Research

Accelerate Brain Cancer Cure
Project Award Recipient,
Paul S. Mischel, M.D.

Accelerate Brain Cancer Cure funds leading investigators with novel translational research ideas that hold significant near-term potential to hasten a cure for brain cancer. One of our awardees, Paul Mischel, M.D., from the David Geffen UCLA School of Medicine, focuses his work on the most common malignant primary brain tumor in adults (glioblastoma), which is among the most lethal of all cancers. Mischel believes primary brain tumor patients are particularly suited to benefit from developments in the growing medical trend of predictive individualized care based on molecular classification and targeted therapy.

 
   
Moving Forward with New Leadership
Message from Kate Carr
Accelerate Brain Cancer
Cure Announces its 2006 Project Award Recipients
Spotlight on Research
Paul S. Mischel, M.D.

 

DONATE NOW TO HELP ACCELERATE A CURE FOR BRAIN CANCER...

You can be our partner in the advancement of research to help treat and ultimately cure, brain cancer.

Just click here to make a quick and safe online donation to Accelerate Brain Cancer Cure by using your credit card.

more

   

 

National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) Announcement

National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) announced that GBM will be one of three cancers involved in The Cancer Genome Atlas (TCGA) project, a comprehensive $100 million effort to advance the understanding of the molecular basis of cancer through genome analysis technologies.

more

   

 

 

 

For questions, comments, or if you know of someone who would like to receive an electronic copy of Advance, please send and email to admin@abc2.org or contact Lindsey Stetson at 202.419.3140.

If you would like to be removed from our distribution list, please send an email to: admin@abc2.org.

1717 Rhode Island Ave NW | Suite 700 | Washington, DC 20036
Phone: 202/419-3140 | Fax: 202/419-3141 | Email: admin@abc2.org | www.abc2.org